INTRODUCTION
The concept of the 'hygiene hypothesis' as originally reported by Strachan [1] and extended by Bach [2] has now been further broadened to suggest that the western lifestyle, including diet, affects the gut microbiota, which in turn impacts on innate and adaptive immune function and intestinal immune homeostasis dictating health and disease. This concept discussed in several very recent reviews represents an emerging area of application for the gastroenterologist's understanding of intestinal immunity, as it pertains to care of patients with intestinal disorders due to dysfunction of the mucosal immune system.
A very recent perspective on human nutrition, the gut microbiome and immunity strongly suggests that differences in gut microbiota in various cultures (e.g. developing vs. developed countries) are in part related to diet in that culture [3] . In addition, as diets in cultures are influenced by the western lifestyle, diseases that are more common in western culture, for example, Crohn's disease, are on the increase [4] . In like manner, if the microbiome of groups residing in strikingly different cultures with different diets (e.g. high fiber, vegetarian vs. western processed food diet) are compared, the major families of bacteria phyla differ strikingly and the predisposition to immune-mediated diseases (allergy and autoimmune disease) is enormous [5] .
The role of malnutrition, both restrictive and excessive nutrition, is a major health hazard in the world today. Malnutrition alters gut microbiota and immune function leading to increased infections due to enteropathogens and further undernutrition, for example, a vicious cycle. In like manner, major bacterial families (phyla) in obesity vs. lean individuals are different, including less microbial diversity and an immune system which favors inflammation (metabolic syndrome). These observations strongly link diet to immune dysfunction via an altered gut microbiota. In like manner, nutrient associated molecules, for example, leptin, vitamin D and vitamin A, are also associated with immune function and can contribute to an altered immunologic homeostasis. Furthermore, metabolic products of gut fermentation of undigested polysaccharides in the diet, for example, short-chain fatty acids, can impact the mucosal immune system in positive as well as negative ways, including epigenetic changes. A recent publication suggests that different populations in various countries have clusters of bacteria, termed 'enterotypes', which may react to diet and drugs differently [6] . In fact, the impact of long-term diet on these 'enterotypes' was recently examined and it was suggested that diet and gut microbiota may in fact be important environmental factors on the expression of immune mediated disease [7] .
Finally, it has been reported that the status of lymphocytes, microbiota and intestinal epithelium in the gut can determine whether the gut mediates immunity or metabolic functions [8] . This observation strongly suggests a link between the mucosal immune system and gut metabolism vis-à-vis gut microbiota. This observation is further underscored by a recent report that dietary fat content can promote colitis via an increased in pathogens in an animal model for inflammatory bowel disease (IBD) [9] . These observations are brought to your attention in addition to the section reviews to underscore the relationship between the mucosal immune system and gut microbiota with regard to metabolic dysfunction. Future Immunologic Sections in Current Opinion in Gastroenterology will undoubtedly address this association.
WHERE ARE THE WORMS?
In this Immunologic Section of Current Opinion in Gastroenterology, Elliott and Weinstock (pp. 551-556) review our current understanding of 'how helminths influence intestinal inflammation and mucosal immune responses'. They suggest that as industrialized countries become more highly hygienic, for example, the 'hygiene hypothesis', with public health measures, vaccinations, use of antibiotics and antihelminthics, there has been a steady rise inimmune-mediated inflammatory diseases such as IBD and autoimmune diseases such as celiac disease. They suggest from recent studies that chronic helminth infestation may predispose to gene variance that may result in less IBD due to stimulation of both innate and adaptive immune responses, which tends to inhibit inflammation and to prevent IBD expression. The authors suggest that because parasites must reside in immune competent hosts they have survived by providing a stimulus to mucosal immune cells to limit inflammation by activating regulatory T-cell cytokines [e.g., interleukin (IL)-10 and transforming growth factor (TGF)b] that prevent their expulsion but at the same time reduce inflammation caused by colonizing microbiota. As countries become more socially and economically secure, they provide a cleaner environment that presumably alters the development of appropriate immune function. Of interest is that the only class of organisms that is lost entirely are intestinal parasites suggesting their important role in the epidemic of immune-mediated disease. Chronic intestinal infections with parasites have resulted in epithelial and lymphocyte gene variance reducing risk factors for inflammatory diseases if the helminths are irradiated. Parasites exist in various classes, but each class has a variety of mechanisms to survive by inhibiting a protective immune response. They tend to stimulate and increase production of anti-inflammatory cytokines, such IL-10, IL-4 and TGFb, and inhibit T-helper cell (Th)-1 cytokines, such as interferon-g and IL-12/IL-23. A variety of parasites have been shown to be protective against animal models for colitis (trinitrobenzene sulfonic acid, IL-10 -/and dextran sulfate sodium colitis). In some instances, the parasite can also stimulate an altered microbiota forming an increase in health promoting bacteria such as Lactobacillus and modify dendritic cells to favor activation of regulatory T cells. The authors have begun to investigate these options. Animal studies of colitis have shown reduced inflammation with a variety parasites or their products and we now have case reports of remission for both ulcerative colitis and Crohn's disease with a deliberate infestation with a benign parasite. Clinical trials are planned with either human hookworm (Necator americaria) or porcine whipworm (Trichers swiss) with encouraging antiinflammatory results. Look for larger trials in the future.
COMMUNICATION BETWEEN GUT MICROBES AND THE BRAIN
In another interesting development in mucosal immune function, Forsythe et al. (pp. 557-562) consider the 'communication between gut microbes and the brain'. In recent years, it has been shown experimentally that the gut microbiota can influence central (CNS) and peripheral nervous system development and function. Gut microbiota disruption has also been noted with stress and anxiety and other elements of mental health. In addition, the vagus nerve has emerged as an important vehicle for communication between gut microbiota and the CNS. What has emerged is evidence that a microbiota-gut-brain access exists that may be important in the health of both organ systems. Using germ-free animals, modified established microbiota and the addition of specific commensal bacteria, experimental studies have shown a reduction in anxiety and the neuronal pathways that mediate this reaction in germfree animals, which is developmentally regulated. Furthermore, oral, nonabsorbable antibiotics have been used to disrupt the distribution of microbiota in the gut, but not total numbers, to reduce a transient behavioral change in the neuromediator levels in compartments of the brain. Animal studies of the effect of bacterial-induced colitis were associated with altered brain function and signaling mediators, which were reversed by the ingestion of probiotics. Yet the infection was not altered. Recently, CNS effects have been shown with use of probiotics in normal animals, including a reduction in plasma glucocorticoid levels, suggesting a reduction in anxiety. Very recent studies have associated an alteration in brainderived neutrophic factors and the expression of arachidonic and dososahexaenoic acid digests in the brain of animals treated with probiotics. These neuro substances have been shown to mediate depression, oxidative stress and other forms of neurotransmission. Recent studies in humans have suggested that probiotic therapy can reduce psychological stress. Finally, evidence now exists that gut bacteria can communicate with the enteric nervous system via intrinsic primary efferent neurons to affect motility and other gut functions. This phenomenon has been demonstrated directly via the vagus nerve as a conduit for gut microbial communication to the brain, particularly with regard to behavior. However, the authors suggest that vagal stimulation is not the only means of communication between gut microbiota and the CNS. Further, noninvasive human studies must be done to begin to apply this concept to human disease.
THE IMPACT OF GUT MICROBES IN ALLERGIC DISEASE
In this review, Russell and Finlay (pp. 563-569) address a changing understanding of the 'hygiene hypothesis'. They underscore the importance of this topic by citing the ever increasing incidence of allergic disease in both pediatric and adult populations in developed countries. An early, appropriate bacterial colonization of the human gut is necessary in infancy for the expression of mucosal immune homeostasis to develop and no expression of disease. They consider epidemiologic and mechanistic studies that support this notion. The absence of appropriate initial colonization (e.g. birth by cesarean section or excessive use of antibiotics in infancy) can predispose to allergic disease in later childhood and adulthood. Recent advances in technology have allowed investigators to identify gut microbiota that are unique to allergy-prone patients and determine the means by which the intestinal immune system controls the atopic phenotype (i.e. expression of T-regulatory cells) or stimulates the allergic response (e.g. an increased Th-2 and IgE response). They cite epidemiologic studies which suggest that early exposure to farm animals during pregnancy and the ingestion of unpasteurized milk prevent allergic expression by stimulating T-regulatory cell and cord blood lymphocytes [see von Mutius (pp. 570-576)]. They review the studies to determine the number of episodes of antibiotics used and the type of antibiotic used in the increased incidence of allergic disease, particularly asthma. The absence of colonization (germ-free) state or dysbiosis (a dysregulated colonization process) influence immune reactions to ingested or inhaled antigens leading to immunemediated allergy. In addition, a nonfunctioning Toll-like receptor (TLR)-4 or short-chain fatty acid receptor in the intestine can also predispose to increased asthma. The authors stress that bacterial colonization must occur at a critical time for appropriate mucosal immune development. Studies of families with allergic history or a high incidence of atopic disease in offsprings have been reported from Finland. When pregnant mothers were given probiotics (Lactobacillus GG) during the final stages of pregnancy and while nursing, their offspring had a 50% reduction in atopic eczema expression compared to controls, which lasted for the first 7 years of life. Other experimental studies have shown that germ-free animals cannot develop tolerance unless they are conventionalized (colonized) in infancy. Microbial colonization can also influence immune function by causing epigenetic changes in immune cell receptors and cytokine release and by stimulating dendritic cells to release cytokines that stimulate a T-regulatory cell response as well as the production of anti-inflammatory cytokines. Finally, the authors conclude that the expression of allergy is a complex process with multiple factors involved and that in-vitro and animal studies translated into human clinical trials do not always substantiate the experimental observation. However, well thought through clinical trials are absolutely necessary before we can use approaches such as probiotic therapy to prevent or treat allergy.
MATERNAL FARM EXPOSURE/INGESTION OF UNPASTEURIZED COW'S MILK AND ALLERGIC DISEASE
In an important new clinical review, as the basis for the increase in allergic disease in developed countries worldwide, von Mutius (pp. 570-576) provides an exciting observation that supports the original 'hygiene hypothesis' by suggesting that early exposure to microbiota during pregnancy influences the development of tolerance to allergens in utero, thereby preventing the expression of allergy in childhood and adulthood. IgE sensitization in infancy to food antigens, house dust, animal dander and pollen have reached almost 50% in affluent countries that have adopted a western lifestyle (diet, use of antibiotics, immunization and sanitation). Yet in a three-country study in Europe (Germany, Austria and Switzerland), pregnant women and their infants living on farms with exposure to farm animals and ingestion of unpasteurized cow's milk have a strikingly reduced expression of atopic dermatitis during infancy and asthma later in life. Although the basis for this reduced risk factor is incompletely understood, it is likely due to an early exposure to increased levels of microbiota at the time when the mucosal immune system is developing. Of interest, ingestion of unpasteurized cow's milk during gestation is inversely related to atopic dermatitis but not asthma. Ingestion of unpasteurized cow's milk by children, however, is associated with reduction in asthma presentation. This observation suggests that time of ingestion, presumably of microbial-containing milk, may affect the expression of disease. These interesting observations may provide a clinical strategy for prevention of allergic disease, as children in urban, nonfarm environment are as protected from allergy as on a farm environment if they ingest unpasteurized cow's milk. However, this has to be monitored very carefully because unpasteurized cow's milk can contain pathogens, which can cause disease. This interesting review of an extension of the 'hygiene hypothesis' may help us to understand the increased incidence of allergic disease in affluent countries.
EPIGENETICS IN INFLAMMATORY BOWEL DISEASE
Janke and Zilbauer (pp. 577-584) provide and excellent review about the topic of recent interest in IBD, namely epigenetics. We now recognize that increased susceptibility and severity to IBD may be affected not only by genetic polymorphisms, for example, altered NOD or TLR-4 receptors, but by environmental factors that affect epigenetic changes, for example, microbiota and bacterial fermentation. The authors suggest that an important contributing factor to the mechanism of IBD may be 'heritable changes to phenotype (e.g. gene expression) that are due to mechanisms other than changes to the underlying DNA sequence' (the definition of epigenetics). Environmental factors at work during developmental plasticity may affect phenotypic expression of gut inflammation that can be passed on from generation to generation. Unlike genetic changes, environmental factors (smoking, diet, stress, etc.) can provide a phenotypic change at various stages within life. Thus, as the authors state this becomes a very important area of investigation for complex diseases such as IBD. Mechanisms of epigenetic change include histone modulation, for example, acetylation or methylation, and DNA methylation. The degree of these processes can either stimulate or inhibit a phenotypic cellular expression of disease. An example of an epigenetic mechanism is the effect of smoking on expression of lung cancer and the lack of folate exposure during pregnancy on neuro-cord defects in the developing fetus. Epigenetic processes tend to occur in complex diseases such as IBD. Emerging evidence suggest that appropriate intestinal colonization is necessary for immune homeostasis. In IBD, genetic polymorphisms do not account for a large percentage of phenotypic IBD cases and in identical twin studies show lack of concordance. This suggests that environmentally produced epigenetic changes may help account for the variation in IBD phenotypic expression with polymorphisms. Nonetheless, epigenetic research as a variable in IBD clinical expression is very likely.
CONCLUSION
In this Immunologic Section of Current Opinion in Gastroenterology, we expand the notion of the 'hygiene hypothesis' to include western lifestyle (diet, sanitation, immunizations and use of antibiotics) to suggest an immunologic basis for the increase in allergy and immune-mediated autoimmune diseases in affluent societies today. We also provide reviews to suggest potential approaches to the prevention of these conditions. It is important for practicing gastroenterologists to understand the association between diet, microbiota and immune homeostasis as we address medical care from a preventive perspective.
